[TREATMENT WITH MEBUTAMATE (AN ANTIHYPERTENSIVE WITH CENTRAL ACTION) OF MENTAL PATIENTS WITH HYPERTENSIVE MANIFESTATIONS].
D000437:Alcoholism; D000959:Antihypertensive Agents; D001007:Anxiety; D001714:Bipolar Disorder; D002219:Carbamates; D003704:Dementia; D004827:Epilepsy; D006801:Humans; D006973:Hypertension; D006993:Hypnotics and Sedatives; D001523:Mental Disorders; D028642:Persons with Psychiatric Disorders; D011618:Psychotic Disorders; D012559:Schizophrenia
D000959:Antihypertensive Agents; D002219:Carbamates; D006993:Hypnotics and Sedatives
ALCOHOLISM; ANTIHYPERTENSIVE AGENTS; ANXIETY; EPILEPSY; HYPERTENSION; HYPNOTICS AND SEDATIVES; MEBUTAMATE; PSYCHOSES, MANIC-DEPRESSIVE; PSYCHOSES, SENILE; SCHIZOPHRENIA
TRATTAMENTO CON "MEBUTAMATO" (ANTI-IPERTENSIVO AD AZIONE CENTRALE) DI MALATI PSICHICI CON MANIFESTAZIONI IPERTENSIVE.